The trajectory of companies tied to flagship drugs like Viagra presents a complex investment picture. While the initial boom of copyright, check here fueled by Viagra's extraordinary popularity, generated substantial profits , the patent expiration in key markets has introduced significant volatility. Investors are now facing the effect of rival me